The Journal of dermatology · 2026
Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025).
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tanemura Atsushi, Oiso Naoki, Okamura Ken, Hiroyasu Sho, Araki Yuta, Yang Lingli, Shimomura Yutaka, Yamasaki Kenshi, Murota Hiroyuki, Tsuruta Daisuke, Kawakami Tamihiro, Toriyama Kazuhiro, Morita Akimichi, Sano Shigetoshi, Inoue Shintaro, Matsunaga Kayoko, Suzuki Tamio, Katayama Ichiro
Аннотация
Vitiligo is a common acquired hypopigmented disorder characterized by melanocyte damage and/or loss, primarily resulting from excessive oxidative stress and dysregulated immune responses targeting melanocytes. The initial guidelines for the diagnosis and treatment of vitiligo in Japan were published in Japanese in 2012 and in English in 2013 to provide clinical evidence for vitiligo management. Since then, there has been a substantial accumulation of pathological research and therapeutic evidence. The second guidelines for the diagnosis and treatment of vitiligo in Japan (2025) are presented as an updated resource for clinicians, incorporating worldwide expert recommendations and recent advances in basic and clinical research. These guidelines aim to provide updated knowledge for individuals with vitiligo, public health professionals, scientists, and dermatologists.